home >
articles > diabetes
> intracellular reduced glutathione content in normal and type 2 diabetic
erythrocytes: effect of insulin and (―)epicatechin
Rizvi SI and Zaid MA
Glutathione Articles - Diabetes
Intracellular Reduced
Glutathione Content in Normal and Type 2 Diabetic Erythrocytes: Effect of
Insulin and (―)Epicatechin
Rizvi SI and Zaid MA
Journal of Physiology and Pharmacology. 2001; 52(3):483-488.
> download
full text version as a PDF
ABSTRACT
Catechins, polyphenolic compounds belonging to flavanoid family, have been reported to posses insulin-like properties and their antidiabetic actions have also been documented. Recently catechins have received much attention as strong anti-oxidative agents. Since oxidative stress has been implicated in the development of diabetic complications and GSH plays an important role in portection against oxidative damages, we have studied the in vitro effect of (―)epicatechin and insulin on the reduced glutathione content in normal and type 2 diabetic erythrocytes. The GSH content was significantly lower (p < 0.001) in type 2 diabetic patients as compared to normal individuals. In vitro insulin treatment (10-9 M) resulted in increase in the GSH content in both normal and type 2 diabetic erythrocytes. (―)Epicatechin (1mM) also resulted in an increase in erythrocyte GSH content in both normal and type 2 diabetic erythrocytes. Insulin gave a pronounced dose-responsive effect: maximum increase at higher and lower insulin concentrations. (―)Epicatechin did not show a similar dose-responsive effect. Although the exact mechanism by which (―)epicatechin causes elevation of erythrocyte GSH is not clear nevertheless this finding may have important therapeutic implcations. A higher content of dietary flavanoids may thus protect diabetic patients against long-term complications.
Keywords: erythrocyte, glutathione, (―)epicatechin, insulin.
Glutathione Experts | What is Glutathione (GSH)?
| Glutathione Articles |
GSH FAQs
| GSH & Diseases |
Contact
